THE PRECLINICAL CHARACTERIZATION AND DEVELOPMENT OF EPI-7386, AN N-TERMINAL DOMAIN ANDROGEN RECEPTOR INHIBITOR, FOR THE TREATMENT OF PROSTATE CANCER

JOURNAL OF UROLOGY(2020)

Cited 0|Views26
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined